| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_MTO1_0001600 | Intron-Exon-Intron | chr6:74181183-74190528 | chr6:73471460-73480805 | 2705 nt | 0.4000 |
| hsa_MTO1_0001900 | Intron-Exon-Intron | chr6:74181183-74202075 | chr6:73471460-73492352 | 119 nt | 0.4202 |
| hsa_chr6_0619300 | Intergenic-Intergenic | chr6:74181744-74181899 | chr6:73472021-73472176 | 156 nt | 0.3205 |
| hsa_MTO1_0002200 | Exon-Exon | chr6:74183088-74183377 | chr6:73473365-73473654 | 290 nt | 0.4483 |
| hsa_MTO1_0002300 | Exon-Exon | chr6:74183088-74189849 | chr6:73473365-73480126 | 594 nt | 0.4428 |
| hsa_MTO1_0002400 | Intron-Exon | chr6:74183088-74189882 | chr6:73473365-73480159 | 627 nt | 0.4402 |
| hsa_MTO1_0002500 | Exon-Exon | chr6:74183088-74190090 | chr6:73473365-73480367 | 50 nt | 0.6200 |
| hsa_MTO1_0002700 | Exon-Exon | chr6:74183088-74202075 | chr6:73473365-73492352 | 290 nt | 0.4483 |
| hsa_MTO1_0002800 | Exon-Exon | chr6:74183088-74207619 | chr6:73473365-73497896 | 290 nt | 0.4483 |
| hsa_MTO1_0003200 | Exon-Exon | chr6:74189455-74189882 | chr6:73479732-73480159 | 337 nt | 0.4332 |
A review consolidating existing research indicates that the circMTO1 functions as a tumor suppressor in hepatocellular carcinoma [Lee et al. DOI:10.1016/j.biopha.2018.12.052] and sponges miR-630 to reverse temozolomide chemoresistance in glioblastoma [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].